- Advertisement -
CNN: The US Food and Drug Administration has given the go-ahead to remdesivir, making it the first drug specifically approved to treat Covid-19.
Trials of the antiviral drug have shown it may not have significant benefits for some coronavirus patients, but it’s what we have now.
Elsewhere on the medical front, a new report from the Center for Infectious Disease Research and Policy reveals the pandemic is causing “unacceptable” shortages of US drug supplies.
The report says shortages have limited 29 of 40 drugs critical for treating Covid-19 patients, including hydroxychloroquine and fentanyl, as well as 67 out of 156 other critical acute drugs.
- Advertisement -
Comments are closed.